Loading...
Header Logo
Keywords
Last Name
Institution

CAROLYN S HALL

TitleAssistant Professor
InstitutionMD Anderson
DepartmentBreast Surgical Oncology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Lucci A, Hall CS, Patel SP, Narendran B, Bauldry JB, Royal RE, Karhade M, Upshaw JR, Wargo JA, Glitza IC, Wong MKK, Amaria RN, Tawbi HA, Diab A, Davies MA, Gershenwald JE, Lee JE, Hwu P, Ross MI. Circulating Tumor Cells and Early Relapse in Node-positive Melanoma. Clin Cancer Res. 2020 Apr 15; 26(8):1886-1895. PMID: 32015020.
      View in: PubMed
    2. Ng SP, Bahig H, Wang J, Cardenas CE, Lucci A, Hall CS, Meas S, Sarli VN, Yuan Y, Urbauer DL, Ding Y, Ikner S, Dinh V, Elgohari BA, Johnson JM, Skinner HD, Gunn GB, Garden AS, Phan J, Rosenthal DI, Morrison WH, Frank SJ, Hutcheson KA, Mohamed ASR, Lai SY, Ferrarotto R, MacManus MP, Fuller CD. Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling. BMC Cancer. 2018 Sep 19; 18(1):903. PMID: 30231854.
      View in: PubMed
    3. Hall CS, Ross M, Bowman Bauldry JB, Upshaw J, Karhade MG, Royal R, Patel S, Lucci A. Circulating Tumor Cells in Stage IV Melanoma Patients. J Am Coll Surg. 2018 07; 227(1):116-124. PMID: 29746918.
      View in: PubMed
    4. Hall CS, Karhade MG, Bowman Bauldry JB, Valad LM, Kuerer HM, DeSnyder SM, Lucci A. Prognostic Value of Circulating Tumor Cells Identified Before Surgical Resection in Nonmetastatic Breast Cancer Patients. J Am Coll Surg. 2016 07; 223(1):20-9. PMID: 27049782.
      View in: PubMed
    5. Hall CS, Karhade M, Laubacher BA, Kuerer HM, Krishnamurthy S, DeSnyder S, Anderson AE, Valero V, Ueno NT, Li Y, Su X, Lucci A. Circulating Tumor Cells and Recurrence After Primary Systemic Therapy in Stage III Inflammatory Breast Cancer. J Natl Cancer Inst. 2015 Nov; 107(11). PMID: 26374427.
      View in: PubMed
    6. Roland CL, Ross MI, Hall CS, Laubacher B, Upshaw J, Anderson AE, Lucci A. Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study. Melanoma Res. 2015 Aug; 25(4):335-41. PMID: 26011119.
      View in: PubMed
    7. Hall C, Karhade M, Laubacher B, Anderson A, Kuerer H, DeSynder S, Lucci A. Circulating Tumor Cells After Neoadjuvant Chemotherapy in Stage I-III Triple-Negative Breast Cancer. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S552-8. PMID: 25968619.
      View in: PubMed
    8. Karhade M, Hall C, Mishra P, Anderson A, Kuerer H, Bedrosian I, Krishnamurthy S, Lucci A. Circulating tumor cells in non-metastatic triple-negative breast cancer. Breast Cancer Res Treat. 2014 Sep; 147(2):325-33. PMID: 25164970.
      View in: PubMed
    9. Pradeep S, Kim SW, Wu SY, Nishimura M, Chaluvally-Raghavan P, Miyake T, Pecot CV, Kim SJ, Choi HJ, Bischoff FZ, Mayer JA, Huang L, Nick AM, Hall CS, Rodriguez-Aguayo C, Zand B, Dalton HJ, Arumugam T, Lee HJ, Han HD, Cho MS, Rupaimoole R, Mangala LS, Sehgal V, Oh SC, Liu J, Lee JS, Coleman RL, Ram P, Lopez-Berestein G, Fidler IJ, Sood AK. Hematogenous metastasis of ovarian cancer: rethinking mode of spread. Cancer Cell. 2014 Jul 14; 26(1):77-91. PMID: 25026212.
      View in: PubMed
    10. Mosalpuria K, Hall C, Krishnamurthy S, Lodhi A, Hallman DM, Baraniuk MS, Bhattacharyya A, Lucci A. Cyclooxygenase-2 expression in non-metastatic triple-negative breast cancer patients. Mol Clin Oncol. 2014 Sep; 2(5):845-850. PMID: 25054056.
      View in: PubMed
    11. Krishnamurthy S, Bischoff F, Ann Mayer J, Wong K, Pham T, Kuerer H, Lodhi A, Bhattacharyya A, Hall C, Lucci A. Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer. Cancer Med. 2013 Apr; 2(2):226-33. PMID: 23634290.
      View in: PubMed
    12. Lucci A, Hall CS, Lodhi AK, Bhattacharyya A, Anderson AE, Xiao L, Bedrosian I, Kuerer HM, Krishnamurthy S. Circulating tumour cells in non-metastatic breast cancer: a prospective study. Lancet Oncol. 2012 Jul; 13(7):688-95. PMID: 22677156.
      View in: PubMed
    13. Hall C, Krishnamurthy S, Lodhi A, Bhattacharyya A, Anderson A, Kuerer H, Bedrosian I, Singh B, Lucci A. Disseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancer. Cancer. 2012 Jan 15; 118(2):342-8. PMID: 21717428.
      View in: PubMed
    14. Hall C, Lucci A. How heterogeneous cell populations, cancer cell dormancy, and minimal residual disease influence the natural history of cancers. Oncology (Williston Park). 2011 Jan; 25(1):47, 50. PMID: 21361243.
      View in: PubMed
    15. Krishnamurthy S, Cristofanilli M, Singh B, Reuben J, Gao H, Cohen EN, Andreopoulou E, Hall CS, Lodhi A, Jackson S, Lucci A. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer. Cancer. 2010 Jul 15; 116(14):3330-7. PMID: 20564098.
      View in: PubMed
    16. Hall C, Krishnamurthy S, Lodhi A, Mosalpuria K, Kuerer HM, Meric-Bernstam F, Bedrosian I, Hunt KK, Lucci A. Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients. Ann Surg Oncol. 2010 Dec; 17(12):3252-8. PMID: 20559739.
      View in: PubMed
    17. Robertson FM, Woodward WA, Pickei R, Ye Z, Bornmann W, Pal A, Peng Z, Hall CS, Cristofanilli M. Suberoylanilide hydroxamic acid blocks self-renewal and homotypic aggregation of inflammatory breast cancer spheroids. Cancer. 2010 Jun 01; 116(11 Suppl):2760-7. PMID: 20503408.
      View in: PubMed
    18. Singh B, Cook KR, Vincent L, Hall CS, Martin C, Lucci A. Role of COX-2 in tumorospheres derived from a breast cancer cell line. J Surg Res. 2011 Jun 01; 168(1):e39-49. PMID: 20462604.
      View in: PubMed
    19. Singh B, Cook KR, Vincent L, Hall CS, Berry JA, Multani AS, Lucci A. Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells. J Surg Res. 2008 Jun 15; 147(2):240-6. PMID: 18498876.
      View in: PubMed
    20. Lang JE, Hall CS, Singh B, Lucci A. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application? Expert Rev Anticancer Ther. 2007 Oct; 7(10):1463-72. PMID: 17944570.
      View in: PubMed
    21. Bomberger JM, Spielman WS, Hall CS, Weinman EJ, Parameswaran N. Receptor activity-modifying protein (RAMP) isoform-specific regulation of adrenomedullin receptor trafficking by NHERF-1. J Biol Chem. 2005 Jun 24; 280(25):23926-35. PMID: 15805108.
      View in: PubMed
    22. Bomberger JM, Parameswaran N, Hall CS, Aiyar N, Spielman WS. Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking. J Biol Chem. 2005 Mar 11; 280(10):9297-307. PMID: 15613468.
      View in: PubMed
    23. Parameswaran N, Hall CC, Bomberger JM, Spielman WS. Regulation of adrenomedullin signaling in kidney interstitial fibroblasts. Cell Physiol Biochem. 2003; 13(6):391-400. PMID: 14631146.
      View in: PubMed
    24. Parameswaran N, Hall CS, Bomberger JM, Sparks HV, Jump DB, Spielman WS. Negative growth effects of ciglitazone on kidney interstitial fibroblasts: role of PPAR-gamma. Kidney Blood Press Res. 2003; 26(1):2-9. PMID: 12697971.
      View in: PubMed
    25. Parameswaran N, Hall CS, McCabe LR, Spielman WS. Adrenomedullin increases AP-1 expression in rat mesangial cells via activation of protein kinase-A and p38 MAPK. Cell Physiol Biochem. 2003; 13(6):367-74. PMID: 14631143.
      View in: PubMed
    26. Parameswaran N, Hall CS, Bock BC, Sparks HV, Gallo KA, Spielman WS. Mixed lineage kinase 3 inhibits phorbol myristoyl acetate-induced DNA synthesis but not osteopontin expression in rat mesangial cells. Mol Cell Biochem. 2002 Dec; 241(1-2):37-43. PMID: 12482023.
      View in: PubMed
    27. Nowak W, Parameswaran N, Hall CS, Aiyar N, Sparks HV, Spielman WS. Novel regulation of adrenomedullin receptor by PDGF: role of receptor activity modifying protein-3. Am J Physiol Cell Physiol. 2002 Jun; 282(6):C1322-31. PMID: 11997247.
      View in: PubMed
    28. Parameswaran N, Hall CS, Böck BC, Sparks HV, Gallo KA, Spielman WS. Mixed lineage kinase 3 inhibits platelet-derived growth factor-stimulated DNA synthesis and matrix mRNA expression in mesangial cells. Cell Physiol Biochem. 2002; 12(5-6):325-34. PMID: 12438768.
      View in: PubMed
    29. Parameswaran N, Nowak W, Hall CS, Sparks HV, Spielman WS. Cellular and molecular actions of adrenomedullin in glomerular mesangial cells. Peptides. 2001 Nov; 22(11):1919-24. PMID: 11754982.
      View in: PubMed
    30. Hwang KK, Hall CS, Spielman WS, Sparks HV. FK506 promotes adenosine release from endothelial cells via inhibition of adenosine kinase. Eur J Pharmacol. 2001 Aug 10; 425(2):85-93. PMID: 11502273.
      View in: PubMed
    31. Parameswaran N, Nambi P, Hall CS, Brooks DP, Spielman WS. Adrenomedullin decreases extracellular signal-regulated kinase activity through an increase in protein phosphatase-2A activity in mesangial cells. Eur J Pharmacol. 2000 Jan 28; 388(2):133-8. PMID: 10666504.
      View in: PubMed
    32. Gorman MW, He MX, Hall CS, Sparks HV. Inorganic phosphate as regulator of adenosine formation in isolated guinea pig hearts. Am J Physiol. 1997 Feb; 272(2 Pt 2):H913-20. PMID: 9124455.
      View in: PubMed
    33. Adenosine release of the isolated guinea pig heart is regulated by phosphorylation of adenosine kinase. FASEB Journal. 12.
    34. Circulating tumor cells in breast cancer patients. Critical Reviews in Oncogenesis. 21:125-141.
    35. How heterogeneous cell populations, cancer cell dormancy, and minimal residual disease influence the natural history of cancers. Oncology. 25.
    36. Prognostic Value of Circulating Tumor Cells Identified Before Surgical Resection in Nonmetastatic Breast Cancer Patients. Journal of the American College of Surgeons.
    37. Circulating and disseminated tumor cells in breast cancer. Breast Diseases. 23:314-317.
    38. Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes. Breast Diseases. 25:242-243.
    39. Annals of Surgical Oncology. 22:552-558.
    40. Inorganic phosphate as regulator of adenosine formation in isolated guinea pig hearts. American Journal of Physiology - Heart and Circulatory Physiology. 41.
    41. Pooled analysis of the prognostic relevance of circulating tumor cells in primary breast cancer. Clinical Cancer Research. 22:2583-2593.
    42. Circulating tumour cells in early breast cancer - Authors' reply. The Lancet Oncology. 13.
    HALL's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description